The Princess Máxima Center for Pediatric Oncology posted on LinkedIn:
“Two new studies start thanks to funding from KWF Kankerbestrijding (Dutch Cancer Society) – Alpe d’HuZes. Ruben van Boxtel, Maarten Geurts and Friso Calkoen want to be able to predict the effectiveness of CAR T-cell therapy in children with leukemia (B-ALL). And Jorik van Rijn aims to find leads for the development of CAR T cell therapy for children with T-lymphoblastic leukemia or lymphoma (T-LBLL).”
